Page last updated: 2024-12-06

2-ethoxybenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID67252
CHEMBL ID4303266
SCHEMBL ID124831
MeSH IDM0093428

Synonyms (41)

Synonym
134-11-2
o-ethoxybenzoic acid
2-ethoxybenzoic acid ,
benzoic acid, 2-ethoxy-
nsc406710
nsc-406710
benzoic acid, o-ethoxy-
inchi=1/c9h10o3/c1-2-12-8-6-4-3-5-7(8)9(10)11/h3-6h,2h2,1h3,(h,10,11
2-ethoxybenzoic acid, 98%
AC-2854
AKOS000103127
E0044
unii-5in9fdi7tt
ai3-06193
einecs 205-130-3
5in9fdi7tt ,
nsc 406710
benzoic acid, ethoxy-
STL169122
FT-0612207
FS-3178
AM20060501
SCHEMBL124831
2-ethoxy benzoic acid
2-(ethyloxy)benzoic acid
2-ethoxy-benzoic acid
DTXSID3059638
W-108289
ortho-ethoxybenzoic acid
CS-W010809
mfcd00002438
F3145-4971
SY003127
Q4596879
2-ethoxybenzoic-acid
CHEMBL4303266
D70509
2-ethoxybenzoicacid
EN300-20425
PD063458
Z104478128
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1562692Competitive binding affinity to recombinant human LXRbeta-LBD expressed in Escherichia coli BL21 (DE3) at 1 mM incubated for 30 mins by fluorescence polarization binding assay relative to tracer 12019European journal of medicinal chemistry, Sep-15, Volume: 178Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.
AID1562690Binding affinity to recombinant human LXRbeta-LBD expressed in Escherichia coli BL21 (DE3) assessed as inhibitory constant incubated for 30 mins by fluorescence polarization binding assay2019European journal of medicinal chemistry, Sep-15, Volume: 178Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.81 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.09 (4.65)
Search Engine Demand Index38.14 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]